Net revenue and adjusted net income declined year-over-year, with the chemical segment showing growth in revenue and EBITDA, while the steel segment faced significant contraction. Cash position and long-term debt profile improved, and major investments and corporate actions were completed.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.